Literature DB >> 33508567

Automatic segmentation of white matter hyperintensities from brain magnetic resonance images in the era of deep learning and big data - A systematic review.

Ramya Balakrishnan1, Maria Del C Valdés Hernández2, Andrew J Farrall3.   

Abstract

BACKGROUND: White matter hyperintensities (WMH), of presumed vascular origin, are visible and quantifiable neuroradiological markers of brain parenchymal change. These changes may range from damage secondary to inflammation and other neurological conditions, through to healthy ageing. Fully automatic WMH quantification methods are promising, but still, traditional semi-automatic methods seem to be preferred in clinical research. We systematically reviewed the literature for fully automatic methods developed in the last five years, to assess what are considered state-of-the-art techniques, as well as trends in the analysis of WMH of presumed vascular origin.
METHOD: We registered the systematic review protocol with the International Prospective Register of Systematic Reviews (PROSPERO), registration number - CRD42019132200. We conducted the search for fully automatic methods developed from 2015 to July 2020 on Medline, Science direct, IEE Explore, and Web of Science. We assessed risk of bias and applicability of the studies using QUADAS 2.
RESULTS: The search yielded 2327 papers after removing 104 duplicates. After screening titles, abstracts and full text, 37 were selected for detailed analysis. Of these, 16 proposed a supervised segmentation method, 10 proposed an unsupervised segmentation method, and 11 proposed a deep learning segmentation method. Average DSC values ranged from 0.538 to 0.91, being the highest value obtained from an unsupervised segmentation method. Only four studies validated their method in longitudinal samples, and eight performed an additional validation using clinical parameters. Only 8/37 studies made available their methods in public repositories.
CONCLUSIONS: We found no evidence that favours deep learning methods over the more established k-NN, linear regression and unsupervised methods in this task. Data and code availability, bias in study design and ground truth generation influence the wider validation and applicability of these methods in clinical research.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Deep learning; FLAIR hyperintensities; Supervised segmentation; Unsupervised segmentation; White matter hyperintensities; White matter lesions

Year:  2021        PMID: 33508567     DOI: 10.1016/j.compmedimag.2021.101867

Source DB:  PubMed          Journal:  Comput Med Imaging Graph        ISSN: 0895-6111            Impact factor:   4.790


  3 in total

1.  Higher-resolution quantification of white matter hypointensities by large-scale transfer learning from 2D images on the JPSC-AD cohort.

Authors:  Benjamin Thyreau; Yasuko Tatewaki; Liying Chen; Yuji Takano; Naoki Hirabayashi; Yoshihiko Furuta; Jun Hata; Shigeyuki Nakaji; Tetsuya Maeda; Moeko Noguchi-Shinohara; Masaru Mimura; Kenji Nakashima; Takaaki Mori; Minoru Takebayashi; Toshiharu Ninomiya; Yasuyuki Taki
Journal:  Hum Brain Mapp       Date:  2022-05-07       Impact factor: 5.399

2.  Diagnostic performance of deep learning-based automatic white matter hyperintensity segmentation for classification of the Fazekas scale and differentiation of subcortical vascular dementia.

Authors:  Leehi Joo; Woo Hyun Shim; Chong Hyun Suh; Su Jin Lim; Hwon Heo; Woo Seok Kim; Eunpyeong Hong; Dongsoo Lee; Jinkyeong Sung; Jae-Sung Lim; Jae-Hong Lee; Sang Joon Kim
Journal:  PLoS One       Date:  2022-09-15       Impact factor: 3.752

Review 3.  Artificial intelligence and its impact on the domains of universal health coverage, health emergencies and health promotion: An overview of systematic reviews.

Authors:  Antonio Martinez-Millana; Aida Saez-Saez; Roberto Tornero-Costa; Natasha Azzopardi-Muscat; Vicente Traver; David Novillo-Ortiz
Journal:  Int J Med Inform       Date:  2022-08-17       Impact factor: 4.730

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.